Phenoxybenzamine in the Management of Neurogenic Vesical Dysfunction
- 1 December 1976
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 116 (6) , 737-738
- https://doi.org/10.1016/s0022-5347(17)58991-0
Abstract
The clinical effect of phenoxybenzamine, an .alpha. blocking agent, was studied in a series of 37 patients with varying degrees of neurogenic vesical dysfunction. An overall 78% success rate was achieved, with an 86% success rate in patients with reflex neurogenic bladder. Phenoxybenzamine demonstrates excellent results in patients with neurovesical dysfunction who are unable to empty their bladders by other means, and effectiveness regardless of the level of the lesion, cystometric findings or duration of neurogenic vesical disease.This publication has 8 references indexed in Scilit:
- Treatment of Autonomic Dysreflexia with Phenoxybenz AmineJournal of Urology, 1976
- Cholinergic and adrenergic neuroreceptors in urinary tract of female dogs: Evaluation of function with pharmacodynamicsUrology, 1975
- Some Clinical Implications of Adrenergic Receptors in the Urinary TractArchives of Surgery, 1975
- α-Adrenolytic Treatment of the Congenital Neuropathic BladderUrologia Internationalis, 1975
- Phenoxybenzamine in Neurogenic Bladder Dysfunction. I. A Theory of MicturitionJournal of Urology, 1973
- Phenoxybenzamine in Neurogenic Bladder Dysfunction. II. Clinical ConsiderationsJournal of Urology, 1973
- Treatment of urinary incontinence by implantable prosthetic sphincterUrology, 1973
- The Physiology of the Internal Urinary SphincterJournal of Urology, 1970